scispace - formally typeset
M

Matthew J. Grainge

Researcher at University of Nottingham

Publications -  161
Citations -  12236

Matthew J. Grainge is an academic researcher from University of Nottingham. The author has contributed to research in topics: Population & Cohort study. The author has an hindex of 47, co-authored 147 publications receiving 10081 citations. Previous affiliations of Matthew J. Grainge include University of Leicester & Nottingham University Hospitals NHS Trust.

Papers
More filters
Journal ArticleDOI

Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer

TL;DR: It is suggested that tumor-infiltrating CD8(+) T lymphocytes have antitumor activity as judged by their favorable effect on patients' survival and could potentially be exploited in the treatment of breast cancer.
Journal ArticleDOI

Global epidemiology of gout: prevalence, incidence and risk factors

TL;DR: Data from epidemiological studies from diverse regions of the world are synthesized to depict the geographic variation in gout prevalence and incidence, and indicate that the distribution of gout is uneven across the globe, with prevalence being highest in Pacific countries.
Journal ArticleDOI

Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study

TL;DR: Patients with inflammatory bowel disease had a higher risk of venous thromboembolism than did controls and at the time of a flare, however, this increase in risk was much more prominent than during hospitalised periods.
Journal ArticleDOI

Prognostic Significance of Nottingham Histologic Grade in Invasive Breast Carcinoma

TL;DR: Histologic grade, as assessed by the Nottingham grading system, provides a strong predictor of outcome in patients with invasive breast cancer and should be incorporated in breast cancer staging systems.
Journal ArticleDOI

Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study

TL;DR: Trends in the epidemiology of gout and patterns of urate-lowering treatment (ULT) in the UK general population from 1997 to 2012 are described and patient adherence has improved during the study period, but it remains poor.